海外の治験の状況「1」での検索結果
185件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease
- Crohn's Disease
- Austria, Germany, Hungary, Poland, Russian Federation, Spain, Ukraine
- 2019-02-23
Recruiting
- A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2
- Primary Hyperoxaluria Type 1 (PH1);Primary Hyperoxaluria Type 2 (PH2);Kidney Diseases;Urologic Diseases;Genetic Disease
- New Zealand
- 2019-02-15
Recruiting
- The correlation between the quality of life using the World Health Organization Quality of Life Assessment questionnaire (WHOQOL- BREF) and Glycated Haemoglobin (HbA1c) in patients with diabetes
- Diabetes mellitus type 1 and type 2 Nutritional, Metabolic, Endocrine Diabetes mellitus
- Austria
- 2018-06-05
Recruiting
- Characterization of Two Novel Mutations in the Apob Gene
- Familial Hypobetalipoproteinaemia - Heterozygous Form;Low-LDL-syndrome
- Austria
- 2019-05-22
Recruiting
- Comparative assessment of the absorption of a generic formulation of 2-methyl-1-phenylpropan-2-amine (122-09-8) capsule against the innovator 2-methyl-1-phenylpropan-2-amine (122-09-8) capsule conducted under fed condition in healthy male and female volunteers.
- 2-methyl-1-phenylpropan-2-amine (122-09-8) is a C5 Controlled Drug indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regime of weight reduction
- New Zealand
- 2017-07-27
Recruiting
- Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
- Breast Neoplasms
- Austria, India, Singapore, Taiwan, United Kingdom
- 2011-07-26
Recruiting
- A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
- Glioblastoma;Gliosarcoma
- Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czech Republic, Czechia, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian Federation, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom, United States
- 2015-09-28
Recruiting
- Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin Therapy
- Aneurysmal Subarachnoid Hemorrhage
- Austria
- 2015-07-10
Recruiting
- A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy
- IGA Nephropathy;N02 - Recurrent and persistent haematuria
- Austria, Germany, Hong Kong, Singapore, Switzerland, Taiwan, Province of China, United Kingdom
- 2015-07-08
Recruiting
- Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
- Crohn Disease
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Croatia, Czech Republic, Czechia, Estonia, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, United States
- 2015-03-26